Key Points
We have inserted a FRed reporter cassette into the mouse Csf1r locus.
Expression of CSF1R-FRed is restricted to cells of the mononuclear phagocyte lineage.
CSF1R-FRed is absent from lineage-negative stem cell populations in bone marrow.
Abstract
The proliferation, differentiation, and survival of cells of the mononuclear phagocyte system (MPS; progenitors, monocytes, macrophages, and classical dendritic cells) are controlled by signals from the M-CSF receptor (CSF1R). Cells of the MPS lineage have been identified using numerous surface markers and transgenic reporters, but none is both universal and lineage restricted. In this article, we report the development and characterization of a CSF1R reporter mouse. A FusionRed (FRed) cassette was inserted in-frame with the C terminus of CSF1R, separated by a T2A-cleavable linker. The insertion had no effect of CSF1R expression or function. CSF1R-FRed was expressed in monocytes and macrophages and absent from granulocytes and lymphocytes. In bone marrow, CSF1R-FRed was absent in lineage-negative hematopoietic stem cells, arguing against a direct role for CSF1R in myeloid lineage commitment. It was highly expressed in marrow monocytes and common myeloid progenitors but significantly lower in granulocyte-macrophage progenitors. In sections of bone marrow, CSF1R-FRed was also detected in osteoclasts, CD169+ resident macrophages, and, consistent with previous mRNA analysis, in megakaryocytes. In lymphoid tissues, CSF1R-FRed highlighted diverse MPS populations, including classical dendritic cells. Whole mount imaging of nonlymphoid tissues in mice with combined CSF1R-FRed/Csf1r-EGFP confirmed the restriction of CSF1R expression to MPS cells. The two markers highlight the remarkable abundance and regular distribution of tissue MPS cells, including novel macrophage populations within tendon and skeletal muscle and underlying the mesothelial/serosal/capsular surfaces of every major organ. The CSF1R-FRed mouse provides a novel reporter with exquisite specificity for cells of the MPS.
Footnotes
This work was supported by UK Research and Innovation Medical Research Council (MRC) Grant MR/M019969/1 and by Australian National Health and Medical Research Council Grant GNT1163981 to D.A.H. D.A.H., K.M.I., and A.R.P. receive core support from The Mater Research Foundation. R.R. was supported by a doctoral scholarship (application number 314413, file number 21889) granted by the Centro de Investigación Científica y de Educación Superior de Ensenada, “Nuevo Leon—I2T2, Mexico” Baja California. P.H. was supported by UK Research and Innovation Biotechnology and Biological Sciences Research Council Grant BB/P013732/1. D.D.O. was supported by MRC Grant MR/M010341/1. We acknowledge support from the Microscopy and Cytometry facilities of the Translational Research Institute (TRI). TRI is supported by the Australian Government.
The online version of this article contains supplemental material.
Abbreviations used in this article:
- BM
- bone marrow
- BMDM
- BM-derived macrophage
- cDC
- classical dendritic cell
- CMP
- common myeloid progenitor
- DC
- dendritic cell
- ESC
- embryonic stem cell
- ESDM
- ESC-derived macrophage
- FRed
- FusionRed
- GMP
- granulocyte-macrophage progenitor
- HSC
- hematopoietic stem cell
- LN
- lymph node
- MEP
- megakaryocyte-erythroid progenitor
- MPS
- mononuclear phagocyte system
- MZ
- marginal zone
- RFP
- red fluorescent protein
- sgRNA
- single-stranded guide RNA
- WT
- wild-type.
- Received July 20, 2020.
- Accepted September 23, 2020.
- Copyright © 2020 by The American Association of Immunologists, Inc.
Pay Per Article - You may access this article (from the computer you are currently using) for 1 day for US$37.50
Regain Access - You can regain access to a recent Pay per Article purchase if your access period has not yet expired.